MedTrace Logo

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

NCT04375579 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 205

Last updated 2024-06-26

No results posted yet for this study

Summary

Patients older than 60 years are more and more transplanted. Comprehensive geriatric assessment (CGA) have been developed and are currently used in patients with cancer, it has been correlated with the prognosis. There is still few data in transplanted patients and the aim of this study is to assess these patients before and after transplantation in order to monitor their general health and quality of life (QOF) and correlate them to the prognostic.

Conditions

  • Stem Cell Transplant

Interventions

OTHER

Comprehensive geriatric assessment (CGA)

Questionnaires on nutritional status, autonomy and quality of life

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-03
Primary Completion
2023-10-17
Completion
2024-10-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04375579 on ClinicalTrials.gov